share_log

ETF收评 | 隔夜美股重挫,纳指科技ETF狂跌8%,日经ETF跌逾4%

ETF review: Overnight plunge in US stocks, NASDAQ technology ETF plummeted 8%, ChinaAMC Nomura N225 ETF dropped over 4%.

Gelonghui Finance ·  Sep 4 15:18

On September 4, the three major stock indexes of A-shares collectively adjusted. As of the close, the Shanghai Composite Index fell by 0.67%, the Shenzhen Component Index fell by 0.51%, and the ChiNext Price Index fell by 0.11%. The total turnover of the Shanghai and Shenzhen stock markets was 559.4 billion yuan, a decrease of 21.2 billion yuan compared to the previous day. Over 3,800 stocks in the two markets were in the red. In terms of market performance, the pharmaceutical commerce, solid state battery, insurance, and education sectors led the gains, while the ST sector and consumer electronics concept sector led the declines. In terms of ETFs, another ETF surged in the final trading session, with Hua Xia Fund CSI 300 Growth ETF rising by 1.53%, with a premium rate of 2.09%. The ChinaAMC Nasdaq 100 ETF Fund, which surged in the final trading session yesterday, fell by 5.98% today, with the latest premium/discount rate at -0.11%. The medical sector was strong throughout the day, with GF Fund Medical ETF leading the gains, up 1.32%, and Hwabao Fund Medical ETF up 1.09%. The battery sector continued its rise for two consecutive days, with China Merchants Fund Battery ETF up 1.27% and China Asset Management Fund Battery ETF up 1.22%. The new energy vehicle sector was active, with Guotai Fund New Energy Vehicle ETF up 1%. Overnight, U.S. stocks fell, and the ChinaAMC Technology 50 ETF plummeted by 8.25% today, with the latest premium/discount rate at 9.79%. The ChinaAMC Nasdaq 100 ETF and the Gfnz100 ETF fell by 5.72% and 5.31% respectively. International oil prices fell, with the SPDR Oil & Gas ETF down 4.54%. The Japanese stock market fell by 4%, with the ChinaAMC Nomura N225 ETF down by 4.26%.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment